“…Vinblastine (1) is mainly useful for treating lymphocytic lymphoma, histiocytic lymphoma, Kaposi's sarcoma, and advanced testicular and breast cancer. Vincristine (2), on the other hand, displays curative effects in acute leukemia, rhabdomyosarcoma, neuroblastoma, and other lymphomas. Clinical treatment with these alkaloids is commonly accompanied by toxic side effects, and the typical dose-limiting factor for the former is bone marrow damage and the dose-limiting factor for the latter is neurotoxicity.…”